by Maeve Luthin, JD, Project Coordinator
It’s been a busy two weeks in the research ethics world! Grab some iced coffee and take some time to catch up with current events.
Dirty Medicine: Earlier this month, generic drug manufacturer Ranbaxy pled guilty to federal criminal charges of selling adulterated drugs with the [...] Read more
Spring is in full swing! Take advantage of the mild weather and enjoy the great outdoors while reading the full text of this week’s Research Ethics Roundup selections.
#NIHSequesterImpact: Last week, Francis Collins, director of the National Institutes of Health, [...] Read more
Hopefully April showers have brought you May flowers! We’ve done some weeding ourselves and have found some articles of interest for this week’s edition of our Research Ethics Roundup.
NIH Stops HIV Vaccine Trial: The National Institute of Allergy and Infectious Diseases halted its HVTN 505 study, the largest HIV vaccine study of its kind, after an independent monitoring board found during a routine interim [...] Read more
It’s been a busy two weeks in the research world and we have the articles to prove it. Read on to learn about some of the current issues that are impacting research from court deliberations on gene patents and oral history research to revelations about the regulatory and ethical failures of a study involving premature infants.
Do April showers have you stuck indoors? Take a moment to peruse the latest installment of our Research Ethics Roundup. This week’s issue features articles on a wide range of topics, including how history should remember researchers with checkered pasts, why science tends to favor positive results, and much more.
Building public trust in genomic research: In this response to Read more